Contrast Media/Contrast Agents Market worth 5.53 Billion USD by 2022

PUNE, India, November 23, 2017 /PRNewswire/ --

According to a new market research report "Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022", published by MarketsandMarketstm, the market is expected to reach USD 5.53 Billion by 2022 from an estimated USD 4.57 Billion in 2017, at a CAGR of 3.9%. The key factors driving the growth of this market are increasing approvals for contrast agents and increase in the number of public & private diagnostic centers.

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

Browse 107 Market Data Tables and 42 Figures spread through 176 Pages and in-depth TOC on "Contrast Media/Contrast Agents Market"

https://www.marketsandmarkets.com/Market-Reports/contrast-media-market-911.html

Early buyers will receive 10% customization on this report 

By type, the iodinated contrast media segment is expected to account for the largest share of the market in 2017 

On the basis of type, the Contrast Media Market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media. In 2017, the iodinated contrast media segment is estimated to account for the largest share of the Contrast Media Market. The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=911

By modality, the X-ray/CT segment is expected to account for the largest share of the market in 2017 

On the basis of modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2017, X-ray/CT procedures segment is expected to command the largest share of the global Contrast Media Market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.

Talk To Our Research Analysts: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=911

North America to dominate the market in 2017 

North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for a geographic analysis of the global Contrast Media Market. North America is expected to account for the largest share of the global Contrast Media Market. The large share of North America in the global market is attributed to the increasing number of diagnostic imaging units and examinations, growing aging population & rising prevalence of chronic conditions in the US, significant focus and government investments in the field of medical imaging, and increasing research activities in Canada.

The prominent players in the global Contrast Media Market include GE Healthcare (US), Bracco Imaging (Italy), Bayer (Germany), and Guerbet (France) are the major players operating in the market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).

Browse Related Reports 

Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/contrast-injector-market-96046959.html  

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

https://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html

About MarketsandMarketstm  

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets' flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]

Visit Our Blog@ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets